Trial of Calcium for Preeclampsia Prevention (CPEP): Rationale, design, and methods

Controlled Clinical Trials

Volumn 17, Issue 5, 1996, Pages 442-469

  Levine, Richard J ^a   Esterlitz, Joy R ^b   Raymond, Elizabeth G ^a   DerSimonian, Rebecca ^a   Hauth, John C ^c   Curet, L Ben ^d   Sibai, Baha M ^e   Catalano, Patrick M ^f   Morris, Cynthia D ^g   Clemens, John D ^a   Ewell, Marian G ^b   Friedman, Steven A ^e   Goldenberg, Robert L ^c   Jacobson, Sig Linda ^g   Joffe, Gary M ^d   Klebanoff, Mark A ^a   Petrulis, Alice S ^f   Rigau Perez, Jose G ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b EMMES CORPORATION   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f METROHEALTH MEDICAL CENTER   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

calcium; clinical trial; hypertension; preeclampsia; pregnancy; proteinuria

Indexed keywords

CALCIUM;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PREECLAMPSIA; PREGNANCY; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; UROLITHIASIS;

CALCIUM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; MANAGEMENT INFORMATION SYSTEMS; MULTICENTER STUDIES; NUTRITION ASSESSMENT; PATIENT COMPLIANCE; PATIENT SELECTION; PLACEBOS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; QUALITY CONTROL; RANDOM ALLOCATION; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SAMPLE SIZE; SEVERITY OF ILLNESS INDEX; STATISTICS; UNITED STATES; URINARY CALCULI;

EID: 10544245021     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(96)00106-7     Document Type: Article

References (36)

1. 1. Baird JN. Eclampsia in a lowland gorilla. Am J Obstet Gynecol 1981;14:345-346.
2. 2. Schoendorf K. Personal communication. Data from mortality files of the National Center for Health Statistics - Multiple Causes of Death, 1984-1988. Division of Analysis, National Center for Health Statistics, Hyattsville, MD. February 1992.
3. 3. Sibai BM, Spinnato JA, Watson DL, Hill GA, Anderson GD. Pregnancy outcome in 303 cases with severe preeclamspia. Obstet Gynecol 1984;64:319-325.
4. 4. Davies AM, Dunlop W. Hypertension in pregnancy. In: Barron SL, Thomson AM, eds. Obstetrical Epidemiology London: Academic Press; 1983. pp 167-208.
5. 5. National High Blood Pressure Education Program Working Group. Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 1990;163:1689-1712.
6. 6. Theobold GW. Effect of calcium and vitamins A and D on incidence of pregnancy toxaemia. Lancet 1937;i:1397-1399.
7. 7. The People's League of Health. Nutrition of expectant and nursing mothers. Interim Report, Lancet 1942;ii:10-12.
8. 8. Chaudhuri SK. Calcium deficiency and toxaemia of pregnancy. J Obstet Gynecol (India) 1969;19:313-316.
9. 9. Marya RK, Rathee S, Manrow M. Effect of calcium and vitamin D supplementation on toxaemia of pregnancy. Gynecol Obstet Invest 1987;24:38-42.
10. 10. Montanaro D, Boscutti G, Antonucci F, Messa P, Messa M, Adonati M, Chopuzzo M, Mioni G, Driul P, Tosolini G. Prevention of pregnancy-induced hypertension (P.I.H.) and preeclamspia (P.E.) by oral calcium supplementation: preliminary results. Mineral Metabolism Research in Italy 1986;7:121-124.
11. 11. Lopez-Jaramillo P, Narvaez M, Weigel RM, Yepez R. Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. Br J Obstet Gynaecol 1989;96:648-655.
12. 12. Lopez-Jaramillo P, Narvaez M, Felix C, Lopez A. Dietary calcium supplementation and prevention of pregnancy hypertension. Lancet 1990;335:293.
13. 13. Villar J, Repke JT. Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations. Am J Obstet Gynecol 1990;163:1124-1131.
14. 14. Belizan JM, Villar J, Gonzalez L, Campodonico L, Bergel E. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991;325:1399-1405.
15. 15. Sanchez-Ramos L, Briones DK, Kaunitz AM, DelValle GO, Gaudier FL, Walker CD. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients. Obstet Gynecol 1994;84:349-353.
16. 16. DerSimonian R. Meta-analysis in the design and monitoring of clinical trials. Statistics in Medicine 1996;15:1237-1248.
17. 17. Levine RJ, Raymond E, DerSimonian R, Clemens JD. Preeclampsia prevention with calcium supplementation. Clin Appl Nutr 1992;2:30-38.
18. 18. Egger MM, Smith GD. Misleading meta-analysis. Br Med J 1995;310:25-27.
19. 19. MacGillivray I, Rose GA, Rowe D. Blood pressure survey in pregnancy. Clin Sci 1969;37:395-398.
20. 20. Villar MA, Sibai BM. Clinical significance of elevated mean arterial blood pressure in second trimester and threshold increase in systolic or diastolic pressure during third trimester. Am J Obstet Gynecol 1989;160:419-4123.
21. 21. Taufield PA, Ales KL, Resnick LM, Druzin ML, Gertner JM, Laragh JH. Hypocalciuria in preeclampsia. New Engl J Med 1987;316:715-718.
22. 22. Dupont WD, Plummer WD. Power and sample size calculations: a review and computer program. Controlled Clin Trials 1990;11:116-128.
23. 23. Sibai BM, Caritis SN, Thom E, Klebanoff M, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. New Engl J Med 1993;329:1214-1218.
24. 24. Duley J. Prevention and treatment of pre-eclampsia. Oxford Database of Perinatal Trials Newsletter February 1991: 2-4.
25. 25. Lachin JM, Foulkes MA. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics 1986;42:507-519.
26. 26. Chesley LC. History and epidemiology of pre-eclampsia-eclampsia. Clin Obstet Gynecol 1984;27:801-820.
27. 27. Gleicher N, Boler LR, Norusis M, Del Granado A. Hypertensive diseases of pregnancy and parity. Am J Obstet Gynecol 1986;154:1044-1049.
28. 28. Roberts JM. Pregnancy-related hypertension. In: Creasy RK, Resnick R, eds. Maternal-Fetal Medicine: Principles and Practice, second edition. Philadelphia: Saunders; 1989: 777-823.
29. 29. Fisher KA, Luger A, Spargo BH, Lindheimer MD. Hypertension in pregnancy: clinical-pathological correlations and remote prognosis. Medicine 1981;60:267-276.
30. 30. Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap II, LC. Williams Obstetrics, 19th edition. Norwalk, CT; Appleton & Lange; 1993.
31. 31. Maikranz P, Holley JL, Parks JH, Lindheimer MD, Naragawa Y, Coe FL. Gestational hypercalciuria causes pathological urine calcium oxalate supersaturations. Kidney Int 1989;36:108-113.
32. 32. Ginsberg JM, Chang BS, Matarese RA, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 1983;309:1543-1546.
33. 33. Coe FL, Parks JH. Nephrolithiasis: Pathogenesis and Treatment, 2nd edition. Chicago: Yearbook Medical Publishers, 1988; 11-13.
34. 34. Ishihara S. Ishihara's Tests for Colour Blindness. Tokyo: Kanehara & Co.; 1980.
35. 35. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods, Van Nostrand Reinhold, New York 1982, pp 340-355.
36. 36. National Research Council (U.S.), Subcommittee on the Tenth Edition of the RDAs: Recommended Dietary Allowances. Committee on Dietary Allowances, Food and Nutrition Board, Division of Biological Sciences. Assembly of Life Sciences. National Research Council, 10th rev. ed., National Academy Press, Washington, DC, 1989.